A review paper has been published in the journal Drug Discovery Today discussing the use of systems biology approaches for studyin...
ScandiBio Therapeutics has initiated a Phase II study in patients with COVID-19 using Combined Metabolic Cofactors Supplementation...
The results of a Phase I study have been published in the journal Molecular Systems Biology describing the kinetics of the Combine...
An article has been published in Briefings in Bioinformatics about the heterogeneity in liver diseases. The abnormalities in human...
ScandiBio Therapeutics has initiated a Phase II study in patients with Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) u...
ScandiBio Therapeutics has initiated a Phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) using Combined M...